ClinicalTrials.govpublic full text
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
autoimmune disorders, systemic sclerosis, systemic lupus erythematosus, lupus, lupus nephritis, car nk, car, natural killer, ssc, sle, ln, gvhd, chronic gvhd, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873895
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.